Enalapril Maleate/Lercanidipine Hydrochloride

马来酸依那普利/盐酸乐卡地平

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEnalapril Maleate/Lercanidipine Hydrochloride
Drug Alias NameEnalapril Maleate/Lercanidipine盐酸乐卡地平/马来酸依那普利Enalapril Maleate and Lercanidipine Hydrochloride马来酸依那普利盐酸乐卡地平乐卡地平/依那普利 +[11] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin-converting enzyme inhibitors
TargetsVoltage-gated calcium channelAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date2007/01/01
Country/TerritoryGermany
CombinationsYes Enalapril MaleateLercanidipine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesRecordati Spa
China Registration ClassN/A

Develop Information

Active CompaniesRecordati Spa
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BB02
Related LinksN/A